RecruitingNCT04788277

Investigation Into Detection of Prostate Cancer Using Voided Urine (Prostate VPAC)

Investigation Into Detection of Prostate Cancer Using Voided Urine

Sponsor

Thomas Jefferson University

Enrollment

675 participants

Start Date

Feb 26, 2020

Study Type

OBSERVATIONAL

Conditions

Prostate Carcinoma

Summary

The goal of this project is to detect prostate cancer cells, shed in voided urine, using the optical imaging method developed in our laboratory, which targets VPAC1 and STEAP1 receptors expressed on prostate cancer cells and validates the results with prevailing condition of the patients / volunteers.

Eligibility

Sex: MALEMin Age: 50 YearsMax Age: 79 Years

Plain Language Summary

Simplified for easier understanding

This study is developing and testing urine-based tests to detect prostate cancer. Researchers believe that proteins and markers shed by cancer cells can be found in urine after a prostate exam, offering a less invasive way to diagnose or rule out prostate cancer. Healthy men and men with known prostate cancer are both needed. **You may be eligible if...** - You are male - You are between 50–70 years old (or up to 75 for certain groups) - You have a known prostate cancer diagnosis scheduled for surgical removal (without prior treatment), OR - You are scheduled for a standard prostate cancer screening colonoscopy **You may NOT be eligible if...** - You have previously been treated for prostate cancer (surgery, radiation, or medication) - You do not meet the specific age requirements - You are unwilling to follow all study procedures Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.